Phynova began at the Oxford Science Park in 2002 with a vision of discovering drug candidates by applying new cutting edge technology to medicinal plants. It later broadened its focus to include the development of natural functional ingredients for the consumer healthcare and food industry, which resulted in our postprandial blood glucose management product Reducose®. Phynova has also added development and registration of several new OTC drugs under the guidelines of the EU’s Traditional Medicinal Herbal Products (THMP), the first of which is Phynova Joint and Muscle Relief™.